These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20227968)

  • 1. Effect of oxamniquine on Schistosoma mansoni: some biological and biochemical observations.
    Goldberg M; Gold D; Flescher E; Lengy J
    Biochem Pharmacol; 1980 Mar; 29(5):838-40. PubMed ID: 20227968
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic effects on larval stages of Schistosoma mansoni during infection and re-infection of mice.
    Silva LM; Menezes RM; de Oliveira SA; Andrade ZA
    Rev Soc Bras Med Trop; 2003; 36(3):335-41. PubMed ID: 12908033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
    Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
    Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
    Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

  • 7. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured].
    Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N
    Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of Schistosoma mansoni.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):352-7. PubMed ID: 3589395
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic and molecular aspects of drug resistance in Schistosoma mansoni].
    Pica L; Cioli D
    Ann Ist Super Sanita; 1986; 22(1):153-5. PubMed ID: 3752792
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
    Panic G; Ruf MT; Keiser J
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy.
    Buchter V; Hess J; Gasser G; Keiser J
    Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression and parasitic diseases: experimental Schistosomiasis mansoni.
    Gargione C; Vellosa SA; Hoshino-Shimizu S; Okumura M; Chiodelle SG
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(3):122-8. PubMed ID: 10436644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
    Rugel AR; Guzman MA; Taylor AB; Chevalier FD; Tarpley RS; McHardy SF; Cao X; Holloway SP; Anderson TJC; Hart PJ; LoVerde PT
    Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():8-15. PubMed ID: 32315953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in schistosomiasis.
    Coles GC; Bruce JI; Kinoti GK; Mutahi WT; Dias EP; Katz N
    Trans R Soc Trop Med Hyg; 1986; 80(2):347. PubMed ID: 3787696
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
    Araujo N; Mattos AC; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections.
    Pica-Mattoccia L; Novi A; Cioli D
    Parasitol Res; 1997; 83(7):687-9. PubMed ID: 9272559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of oxamniquine on Schistosoma mansoni in experimentally infected mice].
    Kohn A; Serapiao CJ; Katz N; Dias EP
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):217-27. PubMed ID: 549207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.